Research, explained.

The pooled estimate suggested fewer venous blood clots with Factor Xa inhibitors, but the result was not statistically significant and uncertainty was wide. Major bleeding showed a signal toward increased risk. The balance between possible clot prevention and bleeding remains unresolved for the cancer populations represented in these trials.

Keep in mind: This abstract-based explanation cannot establish the practical benefit–harm balance: events were few, confidence intervals were wide, and the abstract provides neither absolute event rates nor follow-up durations.

Adding either form of electrical stimulation did not produce a statistically significant advantage on the main neck-disability measure. Some secondary pain and function results differed between groups, but none reached clinical significance. The trial therefore provides no clear evidence of a meaningful extra benefit from these additions within the tested program.

Keep in mind: The abstract does not supply effect estimates or confidence intervals for the main outcome. It also provides limited detail about the therapy program, restricting assessment of precision and relevance to other rehabilitation settings.

The review reports consistent associations between ambient ozone exposure and low birth weight, asthma, respiratory disease and obesity in children, including at concentrations below the cited World Health Organization standard. These observational findings raise questions about protection at lower exposures, but they do not establish that ozone alone caused the health outcomes.

Keep in mind: The abstract gives no outcome-specific effect estimates, exposure thresholds or details of adjustment for other influences. It also reports disagreement for many diseases, limiting conclusions beyond the outcomes with more consistent evidence.

Students often reported better mood, anxiety or stress after experiencing virtual nature. However, studies directly comparing virtual nature with flat-screen nature found no statistically significant differences in those outcomes. Improvement after an experience does not by itself establish that virtual reality caused the change or added benefit beyond viewing nature on a screen.

Keep in mind: Most articles were rated fair or poor quality, and the authors caution about sample sizes. The abstract provides no pooled effect estimates or intervention durations, leaving the magnitude and persistence of changes unclear.

The review reports that aerobic exercise improved selected cognitive test results, while mind-body exercise improved participants' reports of cognitive difficulties. Evidence varied by exercise type and outcome. These findings do not establish that every form of exercise improves cognition broadly, or that test-score changes translate into better everyday functioning.

Keep in mind: This abstract-based explanation lacks comparison conditions and intervention durations. The authors identify tolerability during active cancer treatment as an unresolved research priority.

The analysis reported better sleep quality with mindfulness, exercise, yoga, massage, acupuncture, aromatherapy, relaxation and cognitive behavioral therapy compared with control conditions. Mindfulness received the highest statistical ranking. The abstract does not establish how noticeable these improvements were, how long they lasted, or whether the ranking reflects a dependable advantage over other approaches.

Keep in mind: This abstract-based explanation lacks the sleep-quality scale, control details, intervention durations and quality-assessment results. These omissions limit interpretation of the reported benefits and confidence in comparisons between approaches.

The summary reports better balance and postural control with virtual reality than with conventional therapy. It found no statistically significant differences for gait, cognitive function or fatigue in that comparison. Benefits reported against no intervention concerned upper-limb function and quality of life, making the comparison group essential to understanding the findings.

Keep in mind: This record is a summary with commentary on another review. Its abstract gives no numerical effect estimates, follow-up durations or detailed certainty assessments, and the authors describe the evidence as insufficiently clear.

Women with endometriosis had higher levels of an oxidative DNA-damage marker and telomerase-related measures than controls in the pooled analysis. Some genetic variants were also associated with endometriosis. These findings identify biological associations, but they do not show that the markers cause the condition, reliably predict its onset or provide effective treatment targets.

Keep in mind: This abstract-based explanation lacks measurement timing, control-selection details and clinical prediction performance. The telomere-length result came from subgroup and publication-bias adjustment analyses, distinct from the overall biomarker comparisons.

The review found that studies did not measure fatigue in a consistent way. Questionnaires covered different aspects of the experience, and those aspects were often poorly defined. Consequently, a fatigue score from one study cannot automatically be compared with a score from another, making the overall burden of fatigue harder to establish.

Keep in mind: This abstract-based account cannot identify which questionnaire performs best: the abstract does not provide tool-specific reliability or validity results, or enough detail to judge their suitability for individual patients.

The review reported that urinary continence improved in many patients after abdominoplasty, while others described no change or worsening. This suggests a possible functional benefit in the populations studied, but the abstract does not establish that surgery itself caused the improvement or identify who is most likely to experience it.

Keep in mind: The abstract does not describe individual study designs, nonsurgical comparison groups or confidence intervals. Its before-and-after summaries therefore leave uncertainty about causation and the precision of the reported outcomes.

Non-motor symptoms followed varied paths rather than a clear overall pattern by sex. The average increase in symptom frequency and severity was not statistically significant, but gastrointestinal symptoms worsened in both groups. Male sex was associated with higher odds of worsening sexual function, a specific result that should be distinguished from the overall findings.

Keep in mind: The abstract reports only baseline and follow-up ratings and gives no confidence interval for the sexual-function association. Nonsignificant overall results do not establish that symptoms remain stable or that the sexes have equivalent trajectories.

Higher estimated exposure to several air pollutants was associated with poorer lung-function measurements and greater risk of chronic obstructive pulmonary disease, or COPD. Analyses incorporating earlier cohorts supported the pollution–COPD association. Blood markers suggested possible pathways, but these observational results cannot establish that pollution caused each outcome or that the proposed pathways explain it.

Keep in mind: The abstract does not report follow-up duration, pollutant-specific exposure increments or confidence intervals for COPD estimates. Its summary therefore cannot support a precise estimate of risk for a particular exposure change.

The review ranked resistance exercise highest for reducing neuropsychiatric symptoms in older adults with cognitive impairment or dementia. However, the authors emphasized that few studies examined resistance exercise. The ranking is a comparative result within this evidence network, and it does not establish a reliably superior exercise choice for every person in these clinical groups.

Keep in mind: Resistance-exercise evidence was limited, and study risk of bias varied. The abstract also omits intervention durations and the reference groups behind effect estimates, restricting interpretation of the reported comparisons.

Adding protein to resistance training improved pooled strength and muscle-mass outcomes compared with training alone. Creatine improved muscle mass, but its strength result was not statistically significant; HMB showed no statistically significant strength or mass benefit. These results concern healthy older adults and do not identify a universal supplement choice.

Keep in mind: The abstract omits intervention durations, supplement doses and units for muscle-mass estimates. This abstract-based account cannot establish a practical regimen or clarify the size of the reported mass changes.

The analysis mapped how Parkinson's research involving glutamate has developed, identifying increasing publication activity and shifts in prominent topics. Recent attention centered on alpha-synuclein and neuroinflammation. These results describe what researchers publish and cite; they do not demonstrate that a glutamate-focused treatment improves symptoms or changes the course of Parkinson's disease.

Keep in mind: The publication set came from Web of Science, so the map reflects that database's coverage. Bibliometric prominence measures research activity and attention, rather than the strength of evidence for a clinical claim.

Healthy-aging scores increased from baseline among participants receiving the combined program. Most domains also differed significantly between groups after treatment and at follow-up. However, the abstract does not report the direction of those between-group differences. It therefore leaves uncertainty about the program's advantage over the comparison activities.

Keep in mind: This abstract-based account cannot establish the size or direction of the overall between-group effect. Follow-up was brief, and the combined program does not isolate the contribution of either component.

The pooled findings favored acceptance and commitment therapy across psychological problems, therapy-related processes, well-being and coping. Advantages were reported against waiting lists and usual care, but superiority over cognitive behavioral therapy or other active comparisons was not established. Very low evidence quality leaves substantial uncertainty about the apparent benefit.

Keep in mind: This abstract-based account lacks a confidence interval for the pooled effect and assessment timing. Study bias, differences between study results and possible publication bias reduced confidence.

The review examined melatonin added to nonsurgical periodontal treatment and reported a statistically significant pooled difference in probing depth. However, the abstract does not identify the control treatment or explain which direction its standardized estimate favors. This limits what can be concluded about whether adding melatonin improved that measurement.

Keep in mind: Only 3 studies entered the meta-analysis. This abstract-based account lacks the risk-of-bias results, adverse-event information and details of melatonin dose and delivery, limiting interpretation of both benefit and safety.

Adding the tested curcumin formulation to chemotherapy produced higher objective tumor response rates in this trial of advanced breast cancer. The abstract also reports better progression-free survival and treatment tolerance, without numerical estimates. These findings do not establish longer overall survival or benefits for other cancers or curcumin products.

Keep in mind: Abstract-only reporting leaves blinding, chemotherapy regimens and detailed adverse-event counts unspecified. Missing progression-free survival estimates also prevent assessment of the size and precision of that reported benefit.

The study reported lower internet addiction symptoms, boredom and decision-making deficits after body awareness psychotherapy, alongside improvements in time perception and executive functions. Its statistical analyses linked symptom improvements with changes in cognitive and emotional regulation. However, the abstract gives no effect sizes or clearly specified between-group estimates, limiting interpretation of the benefit.

Keep in mind: The abstract does not report longer follow-up, adverse events or numerical changes on the symptom scales. Findings from students with a diagnosed disorder do not directly establish benefits for other internet users.

The tested collagen combination did not demonstrate better pain relief, knee function, rescue medication use or patient satisfaction than placebo during the study. Both groups improved over time, so those improvements alone cannot establish a supplement benefit. The nonsignificant differences also do not prove the treatments are equivalent or rule out smaller effects.

Keep in mind: The abstract gives no between-group effect estimates or confidence intervals, limiting assessment of what benefit remains plausible. The follow-up does not resolve longer-term effects, and the findings concern this particular collagen combination.

The review found higher odds of cardiac adverse events with first- and third-generation EGFR inhibitors than with placebo. Direct pooled comparisons also linked third-generation drugs with more cardiovascular adverse events than first-generation drugs. These are treatment-specific safety findings in people with EGFR-mutated lung cancer, rather than an assessment of each drug's overall benefits and harms.

Keep in mind: The abstract summarizes several drugs and cardiovascular outcomes. It does not provide the individual patient characteristics or benefit data needed to translate these pooled safety comparisons into a treatment choice.

This pilot primarily tested whether online training for managers and a larger evaluation were workable. Managers generally found the program usable and useful, and their questionnaire scores improved. However, employee outcomes were inconclusive and later follow-up participation was poor. The study therefore supports further evaluation more clearly than a claim of improved employee mental health.

Keep in mind: Manager retention fell to 24.6% at 6 months, and collecting employee data was difficult. These gaps limit conclusions about sustained changes and whether managers' reported gains translated into better outcomes for their teams.

Sleep deprivation was associated with changes in some heart rate variability measures, while others did not change significantly. The authors interpreted this pattern as possible disruption of autonomic regulation. These physiological measurements do not establish that participants developed cardiovascular disease, and the abstract does not quantify the size of the pooled changes.

Keep in mind: This abstract-based account lacks control conditions, deprivation durations and pooled effect estimates. Differences in measurement methods, sleep-loss duration and control of confounding factors complicate interpretation across studies.